Geode Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.4M Buy
2,606,222
+126,049
+5% +$1.18M ﹤0.01% 1852
2025
Q1
$17.6M Buy
2,480,173
+90,933
+4% +$647K ﹤0.01% 1964
2024
Q4
$27.9M Buy
2,389,240
+45,930
+2% +$536K ﹤0.01% 1780
2024
Q3
$48.2M Buy
2,343,310
+49,367
+2% +$1.01M ﹤0.01% 1450
2024
Q2
$51.3M Buy
2,293,943
+249,686
+12% +$5.59M ﹤0.01% 1349
2024
Q1
$56.2M Buy
2,044,257
+70,988
+4% +$1.95M 0.01% 1273
2023
Q4
$60.2M Buy
1,973,269
+93,024
+5% +$2.84M 0.01% 1222
2023
Q3
$59.5M Buy
1,880,245
+94,298
+5% +$2.98M 0.01% 1117
2023
Q2
$72.8M Buy
1,785,947
+130,556
+8% +$5.32M 0.01% 987
2023
Q1
$61.7M Buy
1,655,391
+63,544
+4% +$2.37M 0.01% 1039
2022
Q4
$55.5M Buy
1,591,847
+217,719
+16% +$7.6M 0.01% 1082
2022
Q3
$76.9M Buy
1,374,128
+81,540
+6% +$4.56M 0.01% 804
2022
Q2
$66.9M Buy
1,292,588
+65,764
+5% +$3.4M 0.01% 918
2022
Q1
$89.2M Sell
1,226,824
-5,668
-0.5% -$412K 0.01% 848
2021
Q4
$146M Buy
1,232,492
+35,402
+3% +$4.19M 0.02% 652
2021
Q3
$161M Buy
1,197,090
+78,310
+7% +$10.5M 0.02% 591
2021
Q2
$181M Buy
1,118,780
+97,742
+10% +$15.8M 0.03% 562
2021
Q1
$81.9M Buy
1,021,038
+158,696
+18% +$12.7M 0.01% 883
2020
Q4
$46.9M Buy
862,342
+120,906
+16% +$6.58M 0.01% 1143
2020
Q3
$14.7M Buy
741,436
+86,081
+13% +$1.71M ﹤0.01% 1734
2020
Q2
$13.8M Buy
655,355
+64,314
+11% +$1.35M ﹤0.01% 1740
2020
Q1
$7.23M Buy
591,041
+42,478
+8% +$519K ﹤0.01% 1931
2019
Q4
$8.05M Sell
548,563
-27,555
-5% -$404K ﹤0.01% 2158
2019
Q3
$7.69M Buy
576,118
+72,033
+14% +$962K ﹤0.01% 2100
2019
Q2
$8.25M Buy
504,085
+101,726
+25% +$1.67M ﹤0.01% 2075
2019
Q1
$6.87M Buy
402,359
+42,880
+12% +$732K ﹤0.01% 2136
2018
Q4
$4.91M Buy
359,479
+17,771
+5% +$243K ﹤0.01% 2242
2018
Q3
$9.78M Buy
341,708
+79,623
+30% +$2.28M ﹤0.01% 1938
2018
Q2
$7.17M Buy
262,085
+62,295
+31% +$1.7M ﹤0.01% 2109
2018
Q1
$4.21M Buy
199,790
+3,865
+2% +$81.5K ﹤0.01% 2347
2017
Q4
$3.77M Buy
195,925
+58,411
+42% +$1.12M ﹤0.01% 2380
2017
Q3
$3.42M Buy
137,514
+43,911
+47% +$1.09M ﹤0.01% 2429
2017
Q2
$1.5M Buy
93,603
+17,508
+23% +$280K ﹤0.01% 2894
2017
Q1
$1.07M Buy
76,095
+4,291
+6% +$60.5K ﹤0.01% 2983
2016
Q4
$941K Buy
71,804
+3,101
+5% +$40.6K ﹤0.01% 3023
2016
Q3
$1.17M Buy
68,703
+1,357
+2% +$23.1K ﹤0.01% 2859
2016
Q2
$1.44M Buy
+67,346
New +$1.44M ﹤0.01% 2698